2017-11-07

This release includes 255 new terms since the 2017-09-03 release.

• OBI:0002189 local field potential recording
• OBI:0002190 courier organization
• OBI:0002191 courier tracking number
• OBI:0002192 Leica Peloris rapid tissue processor
• OBI:0002193 Thermo Fisher Scientific
• OBI:0002194 Microm Ergostar HM200
• OBI:0002195 microtome blade
• OBI:0002196 Sakura Low profile Accu-Edge microtome blade
• OBI:0002197 tissue section thickness
• OBI:0002198 molecular analysis facility organization
• OBI:0002199 reason for lack of data item
• OBI:0002200 cannot be assessed determination
• OBI:0002201 determination if assay will provide reliable results
• OBI:0002202 GX
• OBI:0002203 pTX
• OBI:0002204 pNX
• OBI:0002205 histologic grade according to AJCC 7th edition
• OBI:0002206 G1: Well differentiated
• OBI:0002207 G2: Moderately differentiated
• OBI:0002208 G3: Poorly differentiated
• OBI:0002209 G4: Undifferentiated
• OBI:0002210 histologic grade according to the Fuhrman Nuclear Grading System
• OBI:0002211 G1 (Fuhrman)
• OBI:0002212 G2 (Fuhrman)
• OBI:0002213 G3 (Fuhrman)
• OBI:0002214 G4 (Fuhrman)
• OBI:0002215 histologic grade for ovarian tumor
• OBI:0002216 histologic grade for ovarian tumor according to a two-tier grading system
• OBI:0002217 Low grade ovarian tumor
• OBI:0002218 High grade ovarian tumor
• OBI:0002219 histologic grade for ovarian tumor according to the World Health Organization
• OBI:0002220 G1 (WHO)
• OBI:0002221 G2 (WHO)
• OBI:0002222 G3 (WHO)
• OBI:0002223 G4 (WHO)
• OBI:0002224 pathologic primary tumor stage for colon and rectum according to AJCC 7th edition
• OBI:0002225 pT0 (colon)
• OBI:0002226 pTis (colon)
• OBI:0002227 pT1 (colon)
• OBI:0002228 pT2 (colon)
• OBI:0002229 pT3 (colon)
• OBI:0002230 pT4a (colon)
• OBI:0002231 pT4b (colon)
• OBI:0002232 pathologic primary tumor stage for lung according to AJCC 7th edition
• OBI:0002233 pT0 (lung)
• OBI:0002234 pTis (lung)
• OBI:0002235 pT1 (lung)
• OBI:0002236 pT1a (lung)
• OBI:0002237 pT1b (lung)
• OBI:0002238 pT2 (lung)
• OBI:0002239 pT2a (lung)
• OBI:0002240 pT2b (lung)
• OBI:0002241 pT3 (lung)
• OBI:0002242 pT4 (lung)
• OBI:0002243 pathologic primary tumor stage for kidney according to AJCC 7th edition
• OBI:0002244 pT0 (kidney)
• OBI:0002245 pT1 (kidney)
• OBI:0002246 pT1a (kidney)
• OBI:0002247 pT1b (kidney)
• OBI:0002248 pT2 (kidney)
• OBI:0002249 pT2a (kidney)
• OBI:0002250 pT2b (kidney)
• OBI:0002251 pT3 (kidney)
• OBI:0002252 pT3a (kidney)
• OBI:0002253 pT3b (kidney)
• OBI:0002254 pT3c (kidney)
• OBI:0002255 pT4 (kidney)
• OBI:0002256 pathologic primary tumor stage for ovary according to AJCC 7th edition
• OBI:0002257 pT0 (ovary)
• OBI:0002258 pT1 (ovary)
• OBI:0002259 pT1a (ovary)
• OBI:0002260 pT1b (ovary)
• OBI:0002261 pT1c (ovary)
• OBI:0002262 pT2 (ovary)
• OBI:0002263 pT2a (ovary)
• OBI:0002264 pT2b (ovary)
• OBI:0002265 pT2c (ovary)
• OBI:0002266 pT3 (ovary)
• OBI:0002267 pT3a (ovary)
• OBI:0002268 pT3b (ovary)
• OBI:0002269 pT3c (ovary)
• OBI:0002270 pathologic lymph node stage for colon and rectum according to AJCC 7th edition
• OBI:0002271 pN0 (colon)
• OBI:0002272 pN1 (colon)
• OBI:0002273 pN1a (colon)
• OBI:0002274 pN1b (colon)
• OBI:0002275 pN1c (colon)
• OBI:0002276 pN2 (colon)
• OBI:0002277 pN2a (colon)
• OBI:0002278 pN2b (colon)
• OBI:0002279 pathologic lymph node stage for lung according to AJCC 7th edition
• OBI:0002280 pN0 (lung)
• OBI:0002281 pN1 (lung)
• OBI:0002282 pN2 (lung)
• OBI:0002283 pN3 (lung)
• OBI:0002284 pathologic lymph node stage for kidney according to AJCC 7th edition
• OBI:0002285 pN0 (kidney)
• OBI:0002286 pN1 (kidney)
• OBI:0002287 pathologic lymph node stage for ovary according to AJCC 7th edition
• OBI:0002288 pN0 (ovary)
• OBI:0002289 pN1 (ovary)
• OBI:0002290 pathologic distant metastases stage for colon according to AJCC 7th edition
• OBI:0002291 cM0 (colon)
• OBI:0002292 cM1 (colon)
• OBI:0002293 cM1a (colon)
• OBI:0002294 cM1b (colon)
• OBI:0002295 pM1 (colon)
• OBI:0002296 pM1a (colon)
• OBI:0002297 pM1b (colon)
• OBI:0002298 pathologic distant metastases stage for lung according to AJCC 7th edition
• OBI:0002299 cM0 (lung)
• OBI:0002300 cM1 (lung)
• OBI:0002301 cM1a (lung)
• OBI:0002302 cM1b (lung)
• OBI:0002303 pM1 (lung)
• OBI:0002304 pM1a (lung)
• OBI:0002305 pM1b (lung)
• OBI:0002306 pathologic distant metastases stage for kidney according to AJCC 7th edition
• OBI:0002307 cM0 (kidney)
• OBI:0002308 cM1 (kidney)
• OBI:0002309 pM1 (kidney)
• OBI:0002310 pathologic distant metastases stage for ovary according to AJCC 7th edition
• OBI:0002311 cM0 (ovary)
• OBI:0002312 cM1 (ovary)
• OBI:0002313 pM1 (ovary)
• OBI:0002314 clinical tumor stage group according to AJCC 7th edition
• OBI:0002315 Occult Carcinoma (AJCC 7th)
• OBI:0002316 Stage 0 (AJCC 7th)
• OBI:0002317 Stage I (AJCC 7th)
• OBI:0002318 Stage IIA (AJCC 7th)
• OBI:0002319 Stage IIB (AJCC 7th)
• OBI:0002320 Stage IIC (AJCC 7th)
• OBI:0002321 Stage IIIA (AJCC 7th)
• OBI:0002322 Stage IIIB (AJCC 7th)
• OBI:0002323 Stage IIIC (AJCC 7th)
• OBI:0002324 Stage IVA (AJCC 7th)
• OBI:0002325 Stage IVB (AJCC 7th)
• OBI:0002326 International Federation of Gynecology and Obstetrics cervical cancer stage value specification
• OBI:0002327 Stage IA (FIGO)
• OBI:0002328 Stage IA1 (FIGO)
• OBI:0002329 Stage IA2 (FIGO)
• OBI:0002330 Stage IB (FIGO)
• OBI:0002331 Stage IB1 (FIGO)
• OBI:0002332 Stage IB2 (FIGO)
• OBI:0002333 Stage IIA (FIGO)
• OBI:0002334 Stage IIA1 (FIGO)
• OBI:0002335 Stage IIA2 (FIGO)
• OBI:0002336 Stage IIB (FIGO)
• OBI:0002337 Stage IIIA (FIGO)
• OBI:0002338 Stage IIIB (FIGO)
• OBI:0002339 Stage IVA (FIGO)
• OBI:0002340 Stage IVB (FIGO)
• OBI:0002341 International Federation of Gynecology and Obstetrics ovarian cancer stage value specification
• OBI:0002342 Stage 1 (FIGO)
• OBI:0002343 Stage 1A (FIGO)
• OBI:0002344 Stage 1B (FIGO)
• OBI:0002345 Stage 1C (FIGO)
• OBI:0002346 Stage 2 (FIGO)
• OBI:0002347 Stage 2A (FIGO)
• OBI:0002348 Stage 2B (FIGO)
• OBI:0002349 Stage 2C (FIGO)
• OBI:0002350 Stage 3 (FIGO)
• OBI:0002351 Stage 3A (FIGO)
• OBI:0002352 Stage 3B (FIGO)
• OBI:0002353 Stage 3C (FIGO)
• OBI:0002354 Stage 4 (FIGO)
• OBI:0002355 Stage Unknown (FIGO)
• OBI:0002356 performance status value specification
• OBI:0002357 Eastern Cooperative Oncology Group score value specification
• OBI:0002358 3: symptomatic in bed more than 50% of the day but not bed ridden
• OBI:0002359 2: symptomatic but in bed less than 50% of the day
• OBI:0002360 4: bed ridden
• OBI:0002361 0: asymptomatic
• OBI:0002362 1: symptomatic but fully ambulatory
• OBI:0002363 Karnofsky score vaue specification
• OBI:0002364 100: asymptomatic
• OBI:0002365 80-90: symptomatic but fully ambulatory
• OBI:0002366 60-70: symptomatic but in bed less than 50% of the day
• OBI:0002367 40-50: symptomatic, in bed more than 50% of the day, but not bed ridden
• OBI:0002368 clinical history of cancer
• OBI:0002369 clinical history devoid of cancer
• OBI:0002370 unknown clinical history of cancer
• OBI:0002371 diagnosis of cancer
• OBI:0002372 family clinical history of cancer
• OBI:0002373 aunt clinical history of cancer
• OBI:0002374 brother clinical history of cancer
• OBI:0002375 daughter clinical history of cancer
• OBI:0002376 father clinical history of cancer
• OBI:0002377 mother clinical history of cancer
• OBI:0002378 sister clinical history of cancer
• OBI:0002379 son clinical history of cancer
• OBI:0002380 uncle clinical history of cancer
• OBI:0002381 grandmother clinical history of cancer
• OBI:0002382 grandfather clinical history of cancer
• OBI:0002383 nephew clinical history of cancer
• OBI:0002384 niece clinical history of cancer
• OBI:0002385 diagnosis of infectious disease
• OBI:0002386 diagnosis of hepatitis B
• OBI:0002387 diagnosis of hepatitis C
• OBI:0002388 diagnosis of HIV
• OBI:0002389 clinical history of repeated HIV assays
• OBI:0002390 exposure to second hand smoke
• OBI:0002391 exposure to second hand smoke in household during childhood
• OBI:0002392 exposure to second hand smoke in current household
• OBI:0002393 pregnancy history
• OBI:0002394 number of pregnancies
• OBI:0002395 number of live births
• OBI:0002396 age when gave birth to first child
• OBI:0002397 gynecologic surgery history
• OBI:0002398 hysterectomy history
• OBI:0002399 unilateral oophorectomy history
• OBI:0002400 neither hysterectomy nor oophorectomy history
• OBI:0002401 hormonal birth control use history
• OBI:0002402 hormonal birth control former use history
• OBI:0002403 hormonal birth control current use history
• OBI:0002404 no hormonal birth control use history
• OBI:0002405 hormonal replacement therapy history
• OBI:0002406 delivery form for hormonal replacement therapy
• OBI:0002407 pill delivery form for hormonal replacement therapy
• OBI:0002408 patch delivery form for hormonal replacement therapy
• OBI:0002409 cream delivery form for hormonal replacement therapy
• OBI:0002410 menopausal status
• OBI:0002411 indeterminate menopausal status
• OBI:0002412 premenopausal status
• OBI:0002413 perimenopausal status
• OBI:0002414 postmenopausal status
• OBI:0002415 exposure to environmental and workplace carcinogens history
• OBI:0002416 exposure to arsenic history
• OBI:0002417 exposure to asbestos history
• OBI:0002418 exposure to diesel exhaust history
• OBI:0002419 exposure to chromium history
• OBI:0002420 exposure to silica history
• OBI:0002421 indicator of whether an inclusion criterion was met
• OBI:0002422 indicator of whether all inclusion criteria were met
• OBI:0002423 age of majority inclusion criterion
• OBI:0002424 chemotherapy treatment exclusion criterion
• OBI:0002425 radiation treatment exclusion criteria
• OBI:0002426 chemotherapy treatment within the recent past exclusion criterion
• OBI:0002427 radiation treatment within the recent past exclusion criterion
• OBI:0002428 BMI range inclusion criterion
• OBI:0002429 blood transfusion exclusion criterion
• OBI:0002430 history of metastatic cancer exclusion criterion
• OBI:0002431 intravenous drug use exclusion criterion
• OBI:0002432 history of sex with someone with a history of blood borne infection exclusion criterion
• OBI:0002433 history of sex with someone with a history of intravenous drugs exclusion criterion
• OBI:0002434 HIV exclusion criterion
• OBI:0002435 exposure to blood borne infectious disease exclusion criterion
• OBI:0002436 RNA interactome capture
• OBI:0002437 widefield microscopy
• OBI:0002438 nuclear ligation assay
• OBI:0002439 chromosome conformation capture assay
• OBI:0002440 Hi-C assay
• OBI:0002441 physical examination of individual
• OBI:0002442 hydroxyl-radical footprinting assay
• OBI:0002443 methidiumpropyl-EDTA-iron(II) footprinting assay